홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
LFMD
#3190
LifeMD, Inc. Common Stock
2.6
7
-2.91%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-2.91%
월간 변동
-24.79%
6달 변화
-58.86%
년간 변동율
-46.06%
이전 종가
2.7
5
Open
2.6
7
Bid
Ask
Low
2.6
7
High
2.6
7
양
41
마켓
주식
헬스케어
LFMD
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Total assets
72.56 M
72.46 M
73.61 M
73.56 M
65.98 M
Total liabilities
78.51 M
76.51 M
74.01 M
73.18 M
62.62 M
Total equity
-5.96 M
-4.05 M
-392.75 K
382.38 K
3.37 M
Total liabilities & shareholders' equities
72.56 M
72.46 M
73.61 M
73.56 M
65.98 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
LifeMD Inc
LifeMD, Inc. is a publicly traded American telehealth company. It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications.
뉴스
Hims & Hers Expands Digital Health and Global Platform Strategy
LifeMD: Still My Favorite Bargain On The Market (NASDAQ:LFMD)
LifeMD: Pure Telehealth Play With In-House Pharmacy Integration (NASDAQ:LFMD)
Novo Nordis, 목표 주가 $57로 상향 조정 (BMO)
BMO Capital raises Novo Nordisk stock price target to $57 on market outlook
Hims & Hers Scales Platform-Led Digital Healthcare Access and Care
GoodRx, Jefferies "보유"로 하향...처방 사업 부진
Hims & Hers And HIMZ: Short‑Term Pain From Novo, Long‑Term Opportunity Still Bright (HIMS)
Novo Nordis, BMO 캐피털, 목표 주가 46달러 유지
Novo Nordisk stock price target maintained at $46 by BMO Capital
LifeMD, Wegovy 출시로 ’매수’ 유지
LifeMD stock maintains Buy rating at H.C. Wainwright on Wegovy pill launch